Conference Details - Overview
Continuing Education Information
Physicians: Physicians’ Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians’ Education Resource designates this educational activity for a maximum of 15.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA category 1 CME credit for the PRA from organizations accredited by the ACCME.
Seventh International Symposium on Melanoma and Other Cutaneous Malignancies
Jumeirah Essex House
New York, NY
March 12-13, 2010
Conference Overview
CME-Certified Symposium
The Seventh International Symposium on Melanoma and Other Cutaneous Malignancies will continue a strong history and provide participants with a comprehensive overview of state-of-the-art care of patients with these diseases. Specific topics to be highlighted at this symposium include current risk assessment factors and diagnostic technologies, new prognostic and predictive biomarkers with clinical potential for individualizing treatment, and promising emerging systemic immunotherapies, targeted therapies, and regional therapies for advanced melanoma and other cutaneous malignancies. These topics and the implications for practice will be presented by leading experts in the treatment of these different tumor types. This interactive symposium will also cover practical issues concerning surgical management and adjuvant therapy for these patients. These concepts and practical diagnostic issues will be further reinforced through 2 interactive case-based discussion sessions with the faculty to provide expert insights into their application in practice. Throughout the symposium, participants will also learn about currently accruing high-priority trials and the relevant patient eligibility criteria to enhance enrollment into trials evaluating novel therapeutic regimens in the adjuvant and advanced disease settings for melanoma and other cutaneous malignancies.
This educational program is directed toward medical, surgical, and radiation oncologists and dermatologists interested in the treatment of patients with melanoma and other cutaneous malignancies. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of melanoma and other cutaneous malignancies are also invited to attend.At the conclusion of this symposium, you should be able to:
- Identify the risk of melanoma based on genetic factors and diagnose disease based on dermatologic manifestations
- Interpret the molecular biology and pathogenesis of melanoma in relation to the clinical development of targeted agents for melanoma
- Integrate digital dermoscopy into the diagnosis of melanoma
- Discuss the role of emerging technologies such as telediagnostics and ultrasound in the diagnosis of melanoma
- Integrate the new melanoma classification system into disease management
- Apply sentinel node biopsy appropriately to the surgical management of melanoma
- Discuss the clinical implications of recent trials involving the use of agents designed to abrogate immune tolerance in advanced/metastatic melanoma
- Assess the status of newer targeted agents as monotherapy and in combination with traditional therapies in the management of patients with melanoma
- Identify eligible patients for promising clinical trials
Educational Grants
An educational grant for this activity was provided by:
- Bristol-Myers Squibb
- Merck Oncology
- Provectus Pharmaceuticals, Inc.
- Eisai, Inc.
- Genzyme Oncology, a business unit of Genzyme Corporation